| Name | Title | Contact Details |
|---|
he J. M. Smucker Company operates principally in the manufacturing and marketing of branded food products. Majority of the Company’s sales are in the United States. The Company's operations outside the United States are principally in Canada, although products are exported to other countries as well. The Company operates in three segments: U.S. Retail Coffee, U.S. Retail Consumer Foods, and International, Foodservice and Natural Foods.
Since our founding 10 years ago, we`ve always been a different kind of company. After moving to New York from his native Turkey, our CEO Hamdi Ulukaya thought everyone deserved better options, so he set about making delicious, nutritious, natural, and accessible Greek Yogurt right here in the U.S. Our mission since day one has been to provide better food to more people. And now as the No. 1-selling Greek Yogurt brand in America and the second largest overall yogurt manufacturer, we believe every food maker has a responsibility to provide people with better options, which is why we`re so proud of the way our food is made. From the very first batch that came off the line in Upstate New York, in 2007, our cups have been crafted using only natural, non-GMO ingredients. We refuse to use any preservatives. Our yogurt contains no artificial flavors, artificial sweeteners, or preservatives. It has been a busy 10 years for Chobani. Along our journey, we`ve constantly innovated our offerings to evolve with customer tastes and preferences, leading with values, and putting our people first. As we look to the future, Chobani is reinvigorating its founding mission with a vision to make universal wellness happen sooner using food as a force of good. Our vision builds on the company`s founding mission to provide better food for more people, while laying out how Chobani is defining wellness and where the brand will invest to achieve it: • Nutritional Wellness: Scaling our efforts to provide better food for more people. • Social Wellness: Increasing our investment in the communities we serve and the people who craft our food. • Environmental Wellness: Building a supply chain that ensures the planet`s health. This evolution supports Chobani`s ambition to become a food-focused wellness company and providing better food to all people.
Westfalia Fruit is a leading multinational supplier of fresh fruit and related processed products to international markets. Westfalia grows, sources and ripens, packs, processes and markets sustainably grown avocados year-round. Its vertically integrated supply chain enables Westfalia to market quality fruit from across the globe. Westfalia Fruit has a team dedicated to developing exciting new and innovative value-added products, created to delight our customers and consumers. Such initiatives include avocado oil, chunky guacamole, frozen avocado, and dried fruit - with a plethora of additional concepts nearing release.
Quorn is a meat substitute product originating in the UK and sold primarily in Europe, but is available in 14 countries. Quorn is sold as both a cooking ingredient and as the meat substitute used in a range of prepackaged meals.
Neptune is a biotechnology company engaged primarily in the development and commercialization of marine-derived omega-3 polyunsaturated fatty acids ("PUFAs"). Neptune has a patented process of extracting oils from Antarctic krill, and principally sells omega-3 PUFAs as bulk oil to Neptune`s distributors who commercialize them under their private label primarily in the U.S., European and Australian nutraceutical markets. Neptune`s products generally come in bulk oil or capsule form and serve as a dietary supplement to consumers. Neptune`s head office is located at 545 Promenade du Centropolis, Suite 100, Laval, Quebec. Neptune respectively holds approximately 49% of the participating and voting rights of Acasti and 96% of the voting rights of NeuroBio. Through these subsidiaries, Neptune is also pursuing opportunities in the medical food and prescription drug markets. Acasti and NeuroBio respectively focus on the research and development of safe and therapeutically effective compounds for highly prevalent atherosclerotic conditions, such as cardiometabolic disorders and cardiovascular diseases, and for neurodegenerative and inflammation related conditions. Acasti`s lead prescription drug candidate is CaPre(R), a purified high omega-3 phospholipid concentrate derived from Neptune krill oil being developed to address the prevention and treatment of cardiometabolic disorders, including hypertriglyceridemia, which is characterized by abnormally high levels of triglycerides.